Advanced Enzyme Technologies Analyst Review May 2026
- May 21, 2026
- Posted by: Neeraj Pandey
- Category: News
This Advanced Enzyme Technologies analyst review for May 2026 covers the key data investors need for ADVENZYMES at its current price of Rs 359.75. Advanced Enzyme Technologies (NSE: ADVENZYMES) is a global leader in enzyme manufacturing with a market capitalisation of approximately Rs 4,000 crore, producing specialised enzymes for food, animal health, and pharma. The analyst consensus target of Rs 480 implies meaningful upside, and this Advanced Enzyme Technologies analyst review examines technical levels, business performance, valuation, and key risks for ADVENZYMES through FY27.
Click Here – Get Free Investment Predictions
Advanced Enzyme Technologies Company Snapshot May 2026
Advanced Enzyme Technologies’ proprietary enzyme solutions for baking, animal nutrition, detergents, and pharmaceutical applications are sold in 50 plus countries. The human nutrition and healthcare enzyme segment is the highest-margin vertical. The table below summarises the key data referenced in this Advanced Enzyme Technologies analyst review.
| Parameter | Value |
|---|---|
| NSE Ticker | ADVENZYMES |
| Sector | Specialty Chemicals – Enzymes |
| CMP (May 2026) | Rs 359.75 |
| 52 Week High | Rs 419.00 |
| 52 Week Low | Rs 251.95 |
| Market Cap | Rs 4,000 Crore |
| Trailing P/E | 28x |
| Analyst Consensus Target | Rs 480 |
| Bull Case Target | Rs 580 |
| Bear Case Target | Rs 310 |
Analyst Insight in This Advanced Enzyme Technologies Analyst Review
Senior Research Analyst Ankit Jaiswal flags Advanced Enzyme Technologies as a stock to watch in May 2026. At Rs 359.75, Ankit Jaiswal identifies key support in the Rs 257 to Rs 342 band and resistance near Rs 381. He suggests watching Advanced Enzyme Technologies for a potential move toward Rs 480, subject to Specialty Chemicals – Enzymes sector momentum and Nifty 50 direction. Ankit Jaiswal’s view is one input in this Advanced Enzyme Technologies analyst review and does not constitute a trade recommendation.
Technical Analysis in This Advanced Enzyme Technologies Analyst Review
At Rs 359.75, ADVENZYMES is trading within its 52-week band of Rs 251.95 to Rs 419.00. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.
Near-term support is identified in the Rs 257 to Rs 342 band while resistance is seen in the Rs 381 to Rs 420 zone. A sustained move above Rs 381 could open the path toward the analyst consensus target of Rs 480 as identified in this Advanced Enzyme Technologies analyst review.
Screen the best stocks on the Univest Screener.
Key Support and Resistance Levels
- Support Zone: Rs 257 to Rs 342 – investors tracking this Advanced Enzyme Technologies analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for ADVENZYMES.
- Resistance Zone: Rs 381 to Rs 420 – a sustained close above Rs 381 would be a positive breakout signal worth flagging in this Advanced Enzyme Technologies analyst review.
- Medium-Term Target: The analyst consensus of Rs 480 represents the base-case upside scenario in this Advanced Enzyme Technologies analyst review.
Business Segment Analysis
Food and Baking Enzymes (Global Supply)
This is the primary revenue and margin driver for Advanced Enzyme Technologies, directly supporting the earnings trajectory toward the consensus target of Rs 480.
Animal Nutrition Enzymes (Poultry and Livestock)
This segment adds scale and diversification to Advanced Enzyme Technologies’s business model and is a meaningful EPS contributor through FY27 and FY28.
Human Health and Pharmaceutical Enzymes
This represents the medium-term growth frontier for Advanced Enzyme Technologies and a key re-rating catalyst for the stock over the next 12 to 24 months.
Valuation in This Advanced Enzyme Technologies Analyst Review
At Rs 359.75, Advanced Enzyme Technologies trades at a trailing P/E of 28x. This Advanced Enzyme Technologies analyst review presents three scenarios: a bull case of Rs 580 on strong earnings delivery, a base case of Rs 480 at analyst consensus, and a bear case of Rs 310 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Advanced Enzyme Technologies analyst review.
| Scenario | Target Price | Key Condition |
|---|---|---|
| Bull Case | Rs 580 | Strong earnings delivery and sector re-rating |
| Base Case (Consensus) | Rs 480 | Moderate growth, analyst consensus estimate |
| Bear Case | Rs 310 | Earnings miss or macro headwinds |
Trade Outlook for Advanced Enzyme Technologies
Based on the technical and fundamental analysis in this Advanced Enzyme Technologies analyst review, investors might watch ADVENZYMES near the support zone of Rs 257 to Rs 342 for potential opportunities. A flag above Rs 381 could suggest improving momentum toward Rs 480. This article uses watch-and-flag language only and does not constitute a trade recommendation.
Key Risks for Advanced Enzyme Technologies in FY27
A well-rounded Advanced Enzyme Technologies analyst review must assess downside risks. Key risks for Advanced Enzyme Technologies include a macro slowdown affecting Specialty Chemicals – Enzymes sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in ADVENZYMES.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: Advanced Enzyme Technologies Analyst Review Verdict for 2026
This Advanced Enzyme Technologies analyst review concludes that at Rs 359.75, ADVENZYMES offers a defined risk-reward with a consensus target of Rs 480. The 52-week range of Rs 251.95 to Rs 419.00 provides context on the current entry point. Use this Advanced Enzyme Technologies analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on ADVENZYMES.
Frequently Asked Questions: Advanced Enzyme Technologies Analyst Review 2026
What is the analyst target for Advanced Enzyme Technologies in 2026?
The analyst consensus target is Rs 480, with a bull case of Rs 580 and a bear case of Rs 310. This Advanced Enzyme Technologies analyst review recommends monitoring Q1 FY27 earnings for confirmation.
Is Advanced Enzyme Technologies a good investment at Rs 359.75?
At Rs 359.75 with a P/E of 28x and a consensus target of Rs 480, this Advanced Enzyme Technologies analyst review is constructive for medium to long-term investors in the Specialty Chemicals – Enzymes sector. Always consult a SEBI-registered advisor before investing.
What is Advanced Enzyme Technologies’s 52-week high and low?
The 52-week high is Rs 419.00 and the 52-week low is Rs 251.95. At Rs 359.75, ADVENZYMES is positioned within this range as noted in this Advanced Enzyme Technologies analyst review.
What are the key risks for Advanced Enzyme Technologies?
Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Specialty Chemicals – Enzymes sector as assessed in this Advanced Enzyme Technologies analyst review.
Where can I track live data for Advanced Enzyme Technologies?
Track Advanced Enzyme Technologies’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Advanced Enzyme Technologies analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
